November 30, 2009

MERCK & CO: Evaluating ANDA Notice Related to Emend Patent

COMPANIES: Merck & Co Inc
Subscribe

Merck & Co. Inc. continues to evaluate the information provided with an Abbreviated New Drug Application notice to determine what action should be taken.

In January 2009, the Company received notice…

TO CONTINUE READING,LOGIN or
TOPICS: Biotechnology | Drugs/Pharmaceuticals | Legal Issues, Litigation | Patents, Intellectual Prop. | SEC-Qtrly, Annual Reports | Securities & Exch Comm, US
LOCATIONS: New Jersey | United States